Going Commercial, Part I
Biotech Launches Disappoint: Why and Lessons Learned
By Trista Morrison
Monday, May 23, 2011
Over the past two years, a handful of biotech companies have achieved the ultimate goal: launching their own products and transitioning from clinical to commercial enterprises.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.